1 For patients undergoing primary PCI, clinical guidelines recommend a first medical contact (FMC)-to-device time of <90 minutes for patients presenting to a PCI-capable hospital and <120 minutes for patients presenting to a non-PCI-capable hospital.
population. [6] [7] [8] [9] The challenges in meeting target reperfusion times are often because of system issues that hinder coordination between emergency medical service (EMS) providers and hospitals and competition among hospitals and integrated physician groups. 10 The American Heart Association Mission: Lifeline STEMI Systems Accelerator program was developed and implemented in 16 US metropolitan regions to organize leadership, develop common protocols, and initiate ongoing data collection and timely review to improve the proportion of patients receiving timely coronary intervention. 10 This program significantly but modestly increased the overall proportion of patients meeting guideline goals for FMC-to-device times both for patients presenting directly to a PCI-capable hospital and those transferred from non-PCI-capable hospitals. 10a Few studies have compared the impact of multiple STEMI patient flow care processes on reperfusion times. [11] [12] [13] [14] To our knowledge, no prior studies have determined the specific impact on systems performance of rapidly implementing care processes across multiple heterogeneous STEMI systems as part of a large-scale, national effort. Therefore, the goal of the current study was to (1) determine the uptake of recommended care processes and protocols across hospitals using a pre-and postimplementation survey as part of a large-scale national effort to regionalize STEMI care and (2) determine whether hospitals implementing one of 4 specific key care processes had shorter reperfusion times versus those that did not.
Methods
The STEMI Accelerator intervention was organized and executed between March 2012 and July 2014 in 171 hospitals and 23 809 patients, as previously described. 10, 14 Each region identified a baseline quarter as the preintervention period, with the remaining quarters considered the postintervention period. Project initiation was conducted on a rolling basis over 6 months, and each region specified a quarter (quarters 3 or 4, 2012; or quarter 1, 2013) as the baseline from which to assess subsequent temporal trends in outcomes. The following 16 of 21 regions that applied for participation in the project met enrollment criteria by the baseline data collection quarter and were included: Atlanta, GA; Columbus, OH; Denver, CO; Hartford, CT; Houston, TX; Kern County, CA; Louisville, KY; New York City, NY; Northern New Jersey; Oklahoma City, OK; Philadelphia, PA; Pittsburgh, PA; St. Louis, MO; San Antonio, TX; Tampa, FL; and Wilkes-Barre/Scranton, PA. All hospitals within participating regions were enrolled in the National Cardiovascular Data Registry ACTION Registry-GWTG program (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines), described in more detail below. 15 Each region developed common protocols for STEMI care based on guideline recommendations. A detailed description of the protocol has been published previously. 10 All patients with ongoing ischemic symptoms lasting for >10 minutes but <12 hours and who had ECGdiagnosed ST-segment-elevation or left bundle-branch block were included. In cases where the first ECG did not have diagnostic STsegment-elevation, FMC-to-device time was reset to the time of the first diagnostic ECG.
Reperfusion and Outcomes Data
The ACTION Registry-GWTG 15 is a voluntary quality improvement registry in the United States that includes consecutive patients admitted to participating hospitals with STEMI or non-STEMI. This program is sponsored by the American College of Cardiology and the American Heart Association. Definitions for data elements of the registry are available at https://www.ncdr.com/webncdr/action/ home/datacollection. The National Cardiovascular Data Registry data quality program includes data abstraction training, data quality thresholds for inclusion, site data quality feedback reports, independent auditing, and data validation. An audit of the data has demonstrated chart review agreement in >93% of patients. 16 At participating sites, this registry was either approved by an institutional review board or considered quality assurance data and was, therefore, not subject to institutional review board approval based on individual site determinations. The Duke Clinical Research Institute serves as the data coordinating center to analyze deidentified data for research purposes.
Pre-and Postimplementation Survey
American Heart Association Mission: Lifeline coordinators at each participating hospital were contacted via mail or phone to answer a series of questions related to STEMI processes of care and other hospital procedures (Supplement S1 in the Data Supplement). Respondents answered each question at 2 different time points: (1) prior to implementation of STEMI regionalization (preintervention, quarter 1: region-dependent, but typically between July to September or October to December 2012) and (2) after implementation of STEMI regionalization (postintervention, after quarter 7: July to September 2014).
For the purpose of analyzing the relationship between the uptake of 4 key STEMI care processes and reperfusion times, hospitals were stratified according to pre-and postintervention survey responses: (1) hospitals that did not have the care process in place at baseline, but subsequently implemented the existing care process postintervention; (2) hospitals that had an existing care process in place at baseline; and (3) hospitals that did not have the care process in place at baseline and did not implement postintervention. The 4 care processes evaluated were the following:
• Prehospital cardiac catheterization laboratory activation for patients presenting directly via EMS to a PCI-capable hospital.
• Single call primary PCI transfer protocol for patients presenting to a non-PCI-capable hospital.
WHAT IS KNOWN
• Few studies have compared the impact of multiple ST-segment-elevation myocardial infarction (STEMI) patient flow care processes on reperfusion times.
• No prior studies have determined the specific impact on system performance of rapidly implementing care processes across multiple heterogeneous STEMI systems at a national level.
WHAT THE STUDY ADDS
• Through the American Heart Association STEMI Systems Accelerator Project, the first effort to regionalize STEMI care nationally, we found that hospitals implementing key care processes (preactivation, single call transfer, emergency department bypass for both direct emergency medical service presenters and transfers) had shorter reperfusion times compared with hospitals that did not implement these processes.
• Our results support efforts to continue to optimize STEMI systems, with a focus on these key care processes.
• Emergency department (ED) bypass for patients presenting directly via EMS to a PCI-capable hospital (bypass was defined as <5 minutes in the ED).
• ED bypass for patients transferred from a non-PCI-capable hospital to a PCI-capable hospital (with bypass again defined as <5 minutes in the ED). Out of 171 STEMI Accelerator PCI-capable hospitals in 16 regions, 167 (97%) hospitals completed and returned the care processes survey. No outcomes data were revealed or known to the investigators until all the survey data were collected. Patient-level data, including reperfusion times, were linked to specific hospitals using American Hospital Association numbers. The overall study flow chart is shown in Figure 1 .
Statistical Analysis
Descriptive statistics for continuous and categorical variables were described as medians (interquartile ranges) and numbers (percentages), respectively. Patient characteristics and process measures were compared by use of the Wilcoxon rank-sum test for 2-group comparisons (the Kruskal-Wallis test was used for comparisons of >2 groups) and Pearson's χ 2 or Fisher's exact tests as appropriate. A multivariable logistic regression model was used to estimate the adjusted odds ratio and 95% confidence interval for in-hospital mortality outcome based on variables found to be predictive of inhospital mortality in the ACTION Registry-GWTG risk score 17 : age, baseline creatinine, systolic blood pressure, initial troponin, heart failure on presentation, cardiogenic shock on presentation, heart rate, and a history of peripheral artery disease. In addition to the above variables, out-of-hospital cardiac arrest, a strong predictor of in-hospital mortality in ACTION-Registry GWTG hospitals, 18 was also included in the model. FMC-to-device time data were presented and summarized graphically using mountain plots, which represent a folded-empirical distribution function curve of the data at the 50th percentile (median). 19 All statistical tests were conducted at the 0.05 significance level. Statistical analyses were performed with SAS version 9.2 or higher (SAS Institute Inc, Cary, NC). The project was reviewed by the Duke University Institutional Review Board and classified as exempt.
Results

Pre-and Postimplementation Survey
In the 167 hospitals surveyed, uptake of each of the 4 key processes increased after intervention (Figure 2 ): prehospital activation (62%-91%; P<0.001), single call transfer protocol (45%-70%; P<0.001), and ED bypass for direct presenters (48%-59%; P=0.002) and transfer patients (56%-79%; P=0.001). Uptake of most other care processes also increased after intervention (Supplement S2 in the Data Supplement).
Patient Characteristics and Presentation
Between 2012 quarter 3 and 2014 quarter 1 (7 quarters), 23 809 patients presented with acute STEMI, including 18 267 patients who presented directly to a PCI-capable hospital and 5542 who were transferred from hospitals without PCI capability. Among those presenting to PCI-capable hospitals, 64% (n=11 765) were transported by EMS providers, while 36% (n=6502) arrived by self-transport.
14 For the current analysis, overall patient clinical characteristics did not change between quarter 1 and quarter 7 (Table 1) , with some exceptions. Compared with quarter 1, patients in quarter 7 were more likely to be male (72.2% versus 70.0%; P=0.044), insured through Medicaid (11.0% versus 9.2%; P=0.03), and considered a reperfusion candidate (96.6% versus 93.9%; P<0.0001), but these patients were less likely to have prior heart failure (2.7% versus 3.5%; P=0.025).
Reperfusion Times for Key STEMI Care Processes
There were significant differences in median FMC-to-device times among patients treated at hospitals that implemented preactivation for EMS transport to a PCI-capable hospital compared with nonimplementers (88 minutes for implementers versus 89 minutes for preexisting versus 98 minutes for nonimplementers; P<0.001 for group comparisons; Figure 3A) . Similarly, patients treated at hospitals implementing single call transfer protocols at non-PCI-capable hospitals had shorter median FMC-to-device times (112 versus 128 versus 152 minutes; P<0.001). ED bypass was also associated with shorter FMC-to-device times for both direct presenters (84 versus 88 versus 94 minutes; P<0.001) and transfers (123 versus 127 versus 167 minutes; P<0.001; Figure 3B ).
In-Hospital Mortality
After adjustment for 9 variables associated with increased in-hospital mortality (ACTION Risk Score+cardiac arrest), we found no statistically significant difference in mortality between hospitals for any of the 4 key care processes of preactivation, single call transfer protocol, or ED bypass for both direct presenters and transfers (Table 2) . However, hospitals that implemented all 4 care processes by the end of the STEMI Accelerator program (or had them preexisting) had numerically lower in-hospital mortality (6.0%) compared with those implementing only 1 (6.2%), 2 (6.3%), or 3 (7.3%) processes (Supplemental S3 in the Data Supplement).
Discussion
The overall goal of this study was to determine the impact of rapidly implementing care processes across multiple heterogeneous STEMI systems as part of a large scale, national effort. We found that after implementation of the STEMI Accelerator program, there was a significant uptake in several care processes. Importantly, we found that hospitals implementing the key care processes of prehospital activation of a cardiac catheterization laboratory, single call transfer protocol from an non-PCI-capable facility, or ED bypass for both direct EMS presenters or transfers had shorter median reperfusion times compared with hospitals that did not implement these processes and comparable reperfusion times compared with hospitals that had the process in place at baseline.
Our work extends that of prior observational studies, which found associations between STEMI care processes and improved reperfusion times, including preactivation of the cardiac catheterization laboratory, 20 interfacility transfer for primary PCI, 5 and ED bypass. 3, 4 Some smaller studies have compared the impact of STEMI patient flow care process intervention on outcomes, such as reperfusion times and infarct size. [11] [12] [13] However, to our knowledge, this is the first study to demonstrate the specific impact on systems performance of rapidly implementing care processes across multiple heterogeneous STEMI systems on such a large-scale basis, involving nearly one quarter of all STEMI patients in the United States during this study time period. Furthermore, by merging hospital-level care process data with patientlevel data on reperfusion times, we are able to demonstrate that efforts at implementation were associated with modest reductions in reperfusion times using the most contemporary, guideline-recommended reperfusion metric, FMC-todevice time.
This study has several important implications. First, we show that STEMI systems may be rapidly implemented with data collection, feedback, multidisciplinary team engagement, and importantly, adopting specific key care processes. Second, times to reperfusion in systems implementing processes were comparable to those with preexisting processes. This provides a critical and positive message for regions who have not yet adopted formalized reperfusion protocols, demonstrating that system performance can improve in a timely fashion. As a corollary, our data also demonstrate that hospitals that do not implement key STEMI care processes continue to have the longest reperfusion times. Further, the overall program costs are relatively modest at $USD 1.9 million for the additional resources to implement regionalization across all study regions. This translates into a cost per patient of ≈$USD 80 ($1 900 000/23 809 STEMI patients in Accelerator). We think that this additional expense is fairly modest on a perpatient basis compared with the total cost of a single hospitalization for STEMI patients, recently reported to range from $23 000 to $28 000 based on Nationwide Inpatient Sample data. 21 Overall, these data support efforts to optimize STEMI systems, with ongoing focus on the key processes to reduce FMC-to-device times. There are some limitations. The survey results were reported by representatives in regions, whereby all hospitals were participating in the ACTION Registry-GWTG and, thus, may be at risk for both reporting and selection bias. However, this strategy to assess care process implementation was independent of reperfusion time reporting, which was captured by the ACTION Registry-GWTG; therefore, the findings that care process implementation was associated with shorter reperfusion times are likely robust. We also focused on 4 key care processes and others not studied or yet to be analyzed may be important to reduce reperfusion times. However, these care processes were specifically chosen to be important determinants of system performance 3, 5, 10, 20 and highly modifiable at a hospital and regional level; we now extend these findings to a national level. We have limited power to evaluate subgroups based on individual processes because of unmeasured or unmeasurable system factors, as well as a lack of power to reliably assess impact on mortality, which was neutral in this study. With relatively smaller sample sizes and observational data, it may be unrealistic to expect a significant change in overall mortality during a relatively short follow-up period, particularly when some systems of care were already functioning well at baseline.
14,22 Finally, we are unable to adequately compare the relative benefit of each care process over another because hospitals may have used >1 care process at a time.
The neutral mortality results may also be related to secular trends demonstrating increasing mortality risk in contemporary STEMI populations, 23, 24 which could then offset gains in patients with shorter reperfusion times (survivor-cohort effect). 25 We found numeric (but not statistically significant) increases in both shock (7.5%-8.4%) and cardiac arrest (7.3%-8.1%) at presentation between quarters 1 and 7, suggestive of a temporal increase in risk among STEMI patients within our study (Table 1) . While we were unable to demonstrate a mortality benefit associated with shorter reperfusion times at the population level, the benefit of shorter reperfusion times to decrease mortality at the individual patient level is still clear. 26 As discussed earlier, our study may be underpowered to show a mortality benefit in our population or longer follow-up may be required to demonstrate the impact of implementing such care processes. We did find a numerically lower in-hospital mortality among hospitals that had implemented all 4 care processes by the end of the Accelerator program, compared with those that had implemented 1 to 3 processes (Supplement S3 in the Data Supplement). However, a dose-response trend was not observed between number of processes and mortality; therefore, these results should be interpreted with caution.
In conclusion, this study found that the rapid uptake of several care processes occurred during STEMI Accelerator implementation across multiple STEMI systems within the United States. The implementation of key care processes (preactivation, single call transfer, ED bypass for both direct EMS presenters and transfers) was associated with improved reperfusion times. Efforts to optimize STEMI systems should continue and with a focus of these key care processes. Mountain (folded cumulative distribution at the 50th percentile) plots of first medical contact-to-device times (FMC) according to hospital implementation of prehospital cardiac catheterization activation and single call transfer protocol (A) and emergency department (ED) bypass for patients presenting directly to a percutaneous coronary intervention (PCI)-capable hospital via emergency medical services or those transferred from a non-PCI-capable hospital to a PCI-capable hospital for primary PCI (B). The peak of each mountain plot represents the median reperfusion time (50th percentile, in minutes) for patients in that cohort. 
